Free Trial

DarioHealth (DRIO) Competitors

DarioHealth logo
$0.52 +0.09 (+21.42%)
As of 03:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

DRIO vs. BDMD, VANI, NTRB, CTSO, INO, LUNG, TELA, SPAI, QTI, and SRTS

Should you be buying DarioHealth stock or one of its competitors? The main competitors of DarioHealth include Baird Medical Investment (BDMD), Vivani Medical (VANI), Nutriband (NTRB), Cytosorbents (CTSO), Inovio Pharmaceuticals (INO), Pulmonx (LUNG), TELA Bio (TELA), Safe Pro Group (SPAI), QT Imaging (QTI), and Sensus Healthcare (SRTS). These companies are all part of the "medical equipment" industry.

DarioHealth vs. Its Competitors

Baird Medical Investment (NASDAQ:BDMD) and DarioHealth (NASDAQ:DRIO) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, dividends, risk, media sentiment, profitability, analyst recommendations and institutional ownership.

DarioHealth has a consensus price target of $2.00, suggesting a potential upside of 280.95%. Given DarioHealth's stronger consensus rating and higher probable upside, analysts plainly believe DarioHealth is more favorable than Baird Medical Investment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Baird Medical Investment
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
DarioHealth
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Baird Medical Investment has a net margin of 0.00% compared to DarioHealth's net margin of -162.73%. Baird Medical Investment's return on equity of 0.00% beat DarioHealth's return on equity.

Company Net Margins Return on Equity Return on Assets
Baird Medical InvestmentN/A N/A N/A
DarioHealth -162.73%-65.89%-39.03%

19.8% of Baird Medical Investment shares are owned by institutional investors. Comparatively, 33.4% of DarioHealth shares are owned by institutional investors. 78.9% of Baird Medical Investment shares are owned by insiders. Comparatively, 11.2% of DarioHealth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Baird Medical Investment's average media sentiment score of 0.00 beat DarioHealth's score of -0.16 indicating that Baird Medical Investment is being referred to more favorably in the media.

Company Overall Sentiment
Baird Medical Investment Neutral
DarioHealth Neutral

Baird Medical Investment has higher earnings, but lower revenue than DarioHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Baird Medical InvestmentN/AN/AN/AN/AN/A
DarioHealth$27.15M0.88-$42.75M-$0.66-0.80

Baird Medical Investment has a beta of -1, suggesting that its stock price is 200% less volatile than the S&P 500. Comparatively, DarioHealth has a beta of 1.24, suggesting that its stock price is 24% more volatile than the S&P 500.

Summary

DarioHealth beats Baird Medical Investment on 6 of the 11 factors compared between the two stocks.

Get DarioHealth News Delivered to You Automatically

Sign up to receive the latest news and ratings for DRIO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DRIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DRIO vs. The Competition

MetricDarioHealthMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$23.89M$6.86B$5.76B$9.55B
Dividend YieldN/A1.29%4.53%4.07%
P/E Ratio-0.8026.5630.4325.11
Price / Sales0.8866.17392.2187.48
Price / CashN/A21.6837.0358.50
Price / Book0.376.759.016.20
Net Income-$42.75M$176.42M$3.26B$265.38M
7 Day Performance20.47%-2.53%1.00%-1.25%
1 Month Performance-25.52%-2.23%4.19%-0.81%
1 Year Performance-43.49%7.85%28.39%18.83%

DarioHealth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DRIO
DarioHealth
1.5164 of 5 stars
$0.53
+21.4%
$2.00
+281.0%
-53.0%$23.89M$27.15M-0.80200
BDMD
Baird Medical Investment
N/A$2.13
-6.6%
N/AN/A$81.46MN/A0.00N/A
VANI
Vivani Medical
2.1955 of 5 stars
$1.24
-0.8%
$4.00
+222.6%
-11.6%$74.06MN/A-2.7620News Coverage
NTRB
Nutriband
3.4649 of 5 stars
$6.36
-3.2%
$13.00
+104.4%
+10.5%$73.28M$2.14M-7.0710Short Interest ↓
CTSO
Cytosorbents
2.1278 of 5 stars
$1.10
-5.2%
$5.50
+400.0%
-14.9%$72.80M$35.60M-6.47220News Coverage
Analyst Forecast
Analyst Revision
INO
Inovio Pharmaceuticals
4.0343 of 5 stars
$1.90
+2.2%
$8.80
+363.2%
-74.9%$68.21M$220K-0.73320Analyst Revision
LUNG
Pulmonx
3.9 of 5 stars
$1.60
+2.6%
$7.66
+379.0%
-78.3%$63.56M$83.79M-1.12250
TELA
TELA Bio
3.0464 of 5 stars
$1.70
+7.6%
$4.50
+164.7%
-43.7%$62.59M$69.30M-1.52120
SPAI
Safe Pro Group
0.8098 of 5 stars
$4.06
+5.7%
$8.00
+97.0%
N/A$58.26M$2.17M-5.0711News Coverage
Earnings Report
Gap Down
QTI
QT Imaging
N/A$2.03
+1.5%
N/A+331.0%$55.08M$4.00M0.00N/A
SRTS
Sensus Healthcare
1.7679 of 5 stars
$3.31
-1.2%
$8.00
+141.7%
-53.4%$55.07M$41.81M-55.1740

Related Companies and Tools


This page (NASDAQ:DRIO) was last updated on 8/21/2025 by MarketBeat.com Staff
From Our Partners